APACHE III

Acute Physiology & Chronic Health Evaluation III. A ‘third-generation’ system for estimating the risk of hospital death in adult ICU patients based on physiologic assessments of most severely affected values during the first 24 hours in the ICU and subjecting the results to logistic regression modelling techniques

APACHE III

Acute Physiology & Chronic Health Evaluation Intensive care A 'third-generation' system for estimating the risk of hospital death in adult ICU Pts based on physiological assessments of most severely affected values during the first 24 hrs in the ICU and subjecting the results to logistic regression modeling techniques. See Medisgroups, Prognostic scoring systems.
References in periodicals archive ?
Baseline clinical assessment, investigations, APACHE II, APACHE III and OSF (Organ System Failure) scorings were done on all patients.
Compatible with previous reports, our results also indicated that APACHE III score,[18,25-27] the presence of shock[28] and development of delirium[6] were highly related to mortality in mechanically ventilated patients.
Of 246 admissions, median NICU stay was 4 (1, 61) days; APACHE III score was 56 (16, 145).
Los modelos pronosticos de tercera generacion son el SAPS II (19) y el APACHE III (3), este ultimo no tuvo difusion porque su uso era privado.
APACHE III score has been validated for estimation of prognosis in ICU patients.
To examine the association between APACHE III and SOFA scores and midazolam dose, we used scatter plots and linear regression.
The mean SAPS II score was 65, the mean APACHE II score was 28, and the mean APACHE III score was 113.
Statistical analysis: Risk factors [age, gender, APACHE III score and Multiple Organ Dysfunction Score (MODS) at the admission day, TBSA, the mean length of hospital stay, the mean admission days, operation time, the mean white blood cells (WBC), co-morbidities, transfer from other hospital, invasive device usage and prior broad spectrum antibiotic usage] for NIs were determined using Chi square test and univariate analysis.
Because of the lack of available data to calculate a standard APACHE III score for non-ICU patients, we modified the APACHE III score by excluding variables that were unavailable for non-ICU patients.
The risk of developing CIPNM for ventilated patients can be assessed based on the presence of SIRS and APACHE III scoring.
They also had higher APACHE III scores, which indicated that they were more severely ill, and more comorbidities compared with both control groups.